Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Snape

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
JAMA|January 10, 2008
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trialMatthew D Snape, Kirsten P Perrett, Karen J Ford, et al.
Vaccine|April 12, 2023
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infantsDavid Goldblatt, Nick J Andrews, Carmen L Sheppard, et al.
JAMA|February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trialNicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
The Journal of Infectious Diseases|July 28, 2022
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus InfectionJoseph P McGinley, Gu Lung Lin, Deniz Öner, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccineTeresa Lambe, Alexandra J Spencer, Caitlin E Mullarkey, et al.
Vaccine|March 20, 2023
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in EuropeZhuxin Mao, Xiao Li, Ana Dacosta-Urbieta, et al.
The Journal of Infectious Diseases|September 21, 2022
Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7CKaren S Tiley, Helen Ratcliffe, Merryn Voysey, et al.
The Pediatric Infectious Disease Journal|January 26, 2013
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infantsAmeneh Khatami, Matthew D Snape, Brigitte Ohene-Kena, et al.
BMJ Open|November 10, 2021
Supplementation with <i>Bifidobacterium longum</i> subspecies <i>infantis</i> EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocolAnette-Gabriele Ziegler, Stefanie Arnolds, Annika Kölln, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
JAMA|January 10, 2008
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trialMatthew D Snape, Kirsten P Perrett, Karen J Ford, et al.
Vaccine|April 12, 2023
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infantsDavid Goldblatt, Nick J Andrews, Carmen L Sheppard, et al.
JAMA|February 10, 2012
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trialNicoletta Gossger, Matthew D Snape, Ly-Mee Yu, et al.
BMJ (Clinical Research Ed.)|April 3, 2015
Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trialDavid Pace, Ameneh Khatami, Jennifer McKenna, et al.
The Journal of Infectious Diseases|July 28, 2022
Clinical and Viral Factors Associated With Disease Severity and Subsequent Wheezing in Infants With Respiratory Syncytial Virus InfectionJoseph P McGinley, Gu Lung Lin, Deniz Öner, et al.
The Pediatric Infectious Disease Journal|April 3, 2012
T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccineTeresa Lambe, Alexandra J Spencer, Caitlin E Mullarkey, et al.
Vaccine|March 20, 2023
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in EuropeZhuxin Mao, Xiao Li, Ana Dacosta-Urbieta, et al.
The Journal of Infectious Diseases|September 21, 2022
Nasopharyngeal Carriage of Pneumococcus in Children in England up to 10 Years After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Persistence of Serotypes 3 and 19A and Emergence of 7CKaren S Tiley, Helen Ratcliffe, Merryn Voysey, et al.
The Pediatric Infectious Disease Journal|January 26, 2013
Phase II study of a three-dose primary vaccination course of DTPa-IPV/Hib-MenC-TT followed by a 12-month Hib-MenC-TT booster in healthy infantsAmeneh Khatami, Matthew D Snape, Brigitte Ohene-Kena, et al.
BMJ Open|November 10, 2021
Supplementation with <i>Bifidobacterium longum</i> subspecies <i>infantis</i> EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocolAnette-Gabriele Ziegler, Stefanie Arnolds, Annika Kölln, et al.
Pageof 17